Login to Your Account



Cephalon Pays $100M Up Front for Option to Buy Ception

By Glen Harris


Thursday, January 15, 2009
Cephalon Inc. left its comfort zone of cancer and pain, giving Ception Inc. a $100 million up-front payment for an option to buy the company and its main anti-inflammatory product for an additional $250 million-plus. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription